BCKDK and metabolic dysfunction-associated steatotic liver disease: We also found an association between hepatic BCKDK and ChREBPβ expression in liver samples from humans with NASH (9), but the relationship of the metabolites directly regulated by this axis (i.e., BCKA) to NAFLD has not been examined.